m(6)A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy

An impressive clinical success has been observed in treating a variety of cancers using immunotherapy with programmed cell death‐1 (PD‐1) checkpoint blockade. However, limited response in most patients treated with anti‐PD‐1 antibodies remains a challenge, requiring better understanding of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingling, Hui, Hui, Agrawal, Kriti, Kang, Yuqi, Li, Na, Tang, Rachel, Yuan, Jiajun, Rana, Tariq M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560214/
https://www.ncbi.nlm.nih.gov/pubmed/32964498
http://dx.doi.org/10.15252/embj.2020104514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560214/
https://www.ncbi.nlm.nih.gov/pubmed/32964498
http://dx.doi.org/10.15252/embj.2020104514

Ejemplares similares